TD Waterhouse Canada’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-56,757
Closed -$788K 2428
2026
Q1
$788K Buy
56,757
+2,358
+4% +$35.5K ﹤0.01% 745
2025
Q4
$981K Sell
54,399
-36
-0.1% -$646 0.01% 570
2025
Q3
$1.01M Buy
54,435
+1,458
+3% +$22.9K 0.01% 559
2025
Q2
$838K Buy
52,977
+3,753
+8% +$66.9K 0.01% 561
2025
Q1
$947K Buy
49,224
+1,727
+4% +$36.3K 0.01% 535
2024
Q4
$1.05M Buy
47,497
+859
+2% +$16.5K 0.01% 511
2024
Q3
$770K Buy
46,638
+2,272
+5% +$33.7K 0.01% 541
2024
Q2
$538K Buy
44,366
+39,629
+837% +$443K ﹤0.01% 583
2024
Q1
$51.3K Buy
+4,737
New +$48.3K ﹤0.01% 1040

Other funds holding CLBT

TD Waterhouse Canada's CLBT Position: Q2 2026 in Review

TD Waterhouse Canada sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 56,757 shares — an estimated $788K sold.

TD Waterhouse Canada first reported a position in CLBT in Q1 2024 and held it in 9 quarters. The position peaked at $1.05M in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • TD Waterhouse Canada reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • TD Waterhouse Canada sold 56,757 Cellebrite shares in Q2 2026, an estimated $788K.
  • TD Waterhouse Canada first reported a position in Cellebrite in Q1 2024 and held it in 9 quarters.
  • TD Waterhouse Canada's Cellebrite position peaked at $1.05M in Q4 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.